Diverse group of people sitting at round tables at an event

A new UICC report shows how countries translate cancer plans into real‑world impact, highlighting the governance, financing, and partnerships needed to implement national cancer control plans effectively.
Dr Elisabete Weiderpass

On the occasion of IARC’s 60th anniversary, Director Dr Elisabete Weiderpass speaks about how independent research on cancer risk, data and prevention can better inform policy, and how to ensure that evidence is consistently translated into action.
Healthcare professional reviewing medical imaging on a computer workstation at the Aga Khan University in Keyna, illustrating the use of digital technology in cancer diagnosis and treatment planning.

The Access to Oncology Medicines (ATOM) Coalition partner Cepheid has made its first mRNA precision diagnostics for chronic myeloid leukaemia (CML) monitoring available to low- and lower-middle-income countries (LLMICs).
Fundación Esperanza Nueva
Ethiopia CML Patients Association
Maxcare Foundation Nigeria
CML Zimbabwe Trust
FAQ tobacco control
This FAQ provides clear and accessible answers to the most common questions on tobacco control, outlining why it matters, the health risks of tobacco use, and the policies proven to reduce harm and save lives.
FAQ Tobacco control

This policy aims to support UICC’s commitment to integrity, transparency, and accountability by preventing, detecting, and responding to fraud and corruption across all operations, partnerships, and governance structures.

Anti-corruption and Fraud Policy
Subscribe to